BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takeuchi F, Ikeda S, Tsukamoto Y, Iwasawa Y, Qihao C, Otakaki Y, Ryota O, Yao WL, Narita R, Makoto H, Watashi K, Wakita T, Takeuchi K, Chayama K, Kogure A, Kato H, Fujita T. Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor. PLoS One 2019;14:e0212233. [PMID: 30779774 DOI: 10.1371/journal.pone.0212233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Prescott NA, Bram Y, Schwartz RE, David Y. Targeting Hepatitis B Virus Covalently Closed Circular DNA and Hepatitis B Virus X Protein: Recent Advances and New Approaches. ACS Infect Dis. 2019;5:1657-1667. [PMID: 31525994 DOI: 10.1021/acsinfecdis.9b00249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li Z, Wang F, Liu Y, Zhai D, Zhang X, Ying Q, Jia M, Xue X, Meng J, Li J, Wu X, Li M. Coumarin Derivative N6 as a Novel anti-hantavirus Infection Agent Targeting AKT. Front Pharmacol 2021;12:745646. [PMID: 34938178 DOI: 10.3389/fphar.2021.745646] [Reference Citation Analysis]